Isp V B Ef Lp - Oct 21, 2021 Form 3 Insider Report for Enfusion, Inc. (ENFN)

Role: 10%+ Owner
Signature: ISP V-B EF LP, By: ICONIQ Strategic Partners V-B, L.P., By: ICONIQ Strategic Partners V GP, L.P., By: ICONIQ Strategic Partners V TT GP, Ltd., By: Kevin Foster, Title: Authorized Signatory, /s/ Kevin Foster
Stock symbol: ENFN
Transactions as of: Oct 21, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/21/2021, 09:42 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
holding	ENFN	Class A Common Stock						7,748,000	Oct 21, 2021	Direct	F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENFN	Common Units of Enfusion Ltd. LLC							Oct 21, 2021	Class A Common Stock	5,030,000		By ISP V Main Fund EF LLC	F2, F3, F4, F5

Explanation of Responses:

Id	Content
F1	The shares are held by ISP V-B EF LP ("ISP V-B EF").
F2	The shares are held by ISP V Main Fund EF LLC ("ISP V EF").
F3	ICONIQ Strategic Partners V, L.P. ("ICONIQ V") is the sole managing member of ISP V EF. ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V and ISP V-B EF. ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP.
F4	Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F5	Common Units of Enfusion Ltd. LLC (the "Common Units") are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis (for which the Issuer may substitute cash) following the completion of the Issuer's initial public offering. The Common Units have no expiration date. At the time of any such exchange, an equal number of shares of the Class B common stock of the Issuer held by the Reporting Persons, which have no economic value and entitle holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally, are cancelled.